(Q43627009)

25 November 2017

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis (English)

1 reference

25 November 2017

A J Czaja

1

1 reference

25 November 2017

J E Hay

series ordinal

2

1 reference

25 November 2017

J Rakela

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

25 November 2017

1 reference

25 November 2017

65

1 reference

25 November 2017

1

1 reference

25 November 2017

23-30

1 reference

Subdivisions of idiopathic autoimmune chronic active hepatitis

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Etiology of sporadic hepatitis B surface antigen-negative hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Natural history, clinical features, and treatment of autoimmune hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

A classification of chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

HLA typing and autoantibodies in hepatitis B surface antigen-negative chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962106-5

10.1016/S0025-6196(12)62106-5

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference